The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases
暂无分享,去创建一个
P. Hylemon | T. Wakai | K. Takabe | Huiping Zhou | Y. Hirose | M. Nagahashi | R. Ramanathan | N. Hait | K. Yuza | Masato Nakajima
[1] M. Maceyka,et al. Sphingosine‐1‐phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] M. Komatsu,et al. DNA damage response and sphingolipid signaling in liver diseases , 2016, Surgery Today.
[3] Runping Liu,et al. Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line* , 2015, The Journal of Biological Chemistry.
[4] M. Maceyka,et al. Spinster 2, a sphingosine‐1‐phosphate transporter, plays a critical role in inflammatory and autoimmune diseases , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] Hui-Young Lee,et al. Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice , 2015, Hepatology.
[6] S. Milstien,et al. The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer , 2015, Oncogenesis.
[7] S. Spiegel,et al. Conjugated bile acid–activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression , 2015, Hepatology.
[8] G. Alpini,et al. Bile acid signaling and biliary functions , 2015, Acta pharmaceutica Sinica. B.
[9] P. Hylemon,et al. Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism , 2015, Acta pharmaceutica Sinica. B.
[10] S. Spiegel,et al. Uncleaved ApoM Signal Peptide Is Required for Formation of Large ApoM/Sphingosine 1-Phosphate (S1P)-enriched HDL Particles* , 2015, The Journal of Biological Chemistry.
[11] Sarah Spiegel,et al. Export of sphingosine-1-phosphate and cancer progression , 2014, Journal of Lipid Research.
[12] S. Spiegel,et al. Lysophospholipid receptor nomenclature review: IUPHAR Review 8 , 2014, British journal of pharmacology.
[13] T. Hla,et al. An update on the biology of sphingosine 1-phosphate receptors , 2014, Journal of Lipid Research.
[14] T. Wakai,et al. Sphingosine-1-Phosphate Transporters as Targets for Cancer Therapy , 2014, BioMed research international.
[15] Cheng Luo,et al. Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory , 2014, Nature Neuroscience.
[16] Sarah Spiegel,et al. Sphingolipid metabolites in inflammatory disease , 2014, Nature.
[17] N. Hemdan,et al. Sphingosine 1-Phosphate in Blood: Function, Metabolism, and Fate , 2014, Cellular Physiology and Biochemistry.
[18] A. Yamaguchi,et al. Molecular and physiological functions of sphingosine 1-phosphate transporters. , 2014, Biochimica et biophysica acta.
[19] Todd Evans,et al. Sphingosine 1-phosphate signalling , 2014, Development.
[20] Junlin Qi,et al. Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy , 2013, Disease Models & Mechanisms.
[21] S. Milstien,et al. Sphingosine-1-phosphate in chronic intestinal inflammation and cancer. , 2014, Advances in biological regulation.
[22] S. Spiegel,et al. Hepatic Apolipoprotein M (ApoM) Overexpression Stimulates Formation of Larger ApoM/Sphingosine 1-Phosphate-enriched Plasma High Density Lipoprotein* , 2013, The Journal of Biological Chemistry.
[23] Y. Hannun,et al. Sphingosine‐1‐phosphate receptor 2 , 2013, The FEBS journal.
[24] Yuhuan Wang,et al. Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice , 2013, Journal of Lipid Research.
[25] K. Takabe,et al. Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis , 2013, Biomolecules.
[26] P. Edwards,et al. Pleiotropic roles of bile acids in metabolism. , 2013, Cell metabolism.
[27] Sarah Spiegel,et al. Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] Hardik I. Parikh,et al. Biological Characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a Selective Sphingosine Kinase-2 Inhibitor and Anticancer Agent , 2013, PloS one.
[29] Eugene Y. Kim,et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. , 2013, Cancer cell.
[30] J. Pfeilschifter,et al. Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. , 2012, The Biochemical journal.
[31] Kazuaki Takabe,et al. The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. , 2012, Lymphatic research and biology.
[32] J. Cyster,et al. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. , 2012, Annual review of immunology.
[33] Eugene Y. Kim,et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. , 2012, Cancer research.
[34] S. Spiegel,et al. Conjugated bile acids activate the sphingosine‐1‐phosphate receptor 2 in primary rodent hepatocytes , 2012, Hepatology.
[35] Sarah Spiegel,et al. Sphingosine-1-phosphate signaling and its role in disease. , 2012, Trends in cell biology.
[36] Yinxin Zhang,et al. Impact of bile acids on the growth of human cholangiocarcinoma via FXR , 2011, Journal of hematology & oncology.
[37] S. Milstien,et al. The outs and the ins of sphingosine-1-phosphate in immunity , 2011, Nature Reviews Immunology.
[38] Charles D Smith,et al. Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts , 2011, Cancer biology & therapy.
[39] D. C. Simpson,et al. Sphingosine‐1‐phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] Cheng Luo,et al. SPHINGOSINE-1-PHOSPHATE: A MISSING COFACTOR FOR THE E3 UBIQUITIN LIGASE TRAF2 , 2010, Nature.
[41] Lixin Sun,et al. Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via Gαi-protein-coupled receptors and the AKT pathway[S] , 2010, Journal of Lipid Research.
[42] Sarah Spiegel,et al. Estradiol Induces Export of Sphingosine 1-Phosphate from Breast Cancer Cells via ABCC1 and ABCG2* , 2010, The Journal of Biological Chemistry.
[43] Ying Xu,et al. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning , 2009, The Journal of experimental medicine.
[44] J. Chiang,et al. Bile acids: regulation of synthesis , 2009, Journal of Lipid Research.
[45] Cheng Luo,et al. Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate , 2009, Science.
[46] J. Auwerx,et al. TGR5-mediated bile acid sensing controls glucose homeostasis. , 2009, Cell metabolism.
[47] Timothy D Veenstra,et al. Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation. , 2009, Genes & development.
[48] S. Milstien,et al. “Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets , 2008, Pharmacological Reviews.
[49] J. Liao,et al. Distribution of sphingosine kinase activity and mRNA in rodent brain , 2007, Journal of neurochemistry.
[50] T. Hla,et al. Induction of Vascular Permeability by the Sphingosine-1-Phosphate Receptor–2 (S1P2R) and its Downstream Effectors ROCK and PTEN , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[51] S. Milstien,et al. Sphingosine Kinase Type 2 Activation by ERK-mediated Phosphorylation* , 2007, Journal of Biological Chemistry.
[52] P. Dent,et al. Conjugated Bile Acids Regulate Hepatocyte Glycogen Synthase Activity In Vitro and In Vivo via Gαi Signaling , 2007, Molecular Pharmacology.
[53] S. Spiegel,et al. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin–sensitive mechanism in murine and human hepatocytes , 2005, Hepatology.
[54] J. Wess,et al. Deoxycholyltaurine-induced vasodilation of rodent aorta is nitric oxide- and muscarinic M(3) receptor-dependent. , 2005, European journal of pharmacology.
[55] Jung-Hwan Yoon,et al. Bile acids activate EGF receptor via a TGF-alpha-dependent mechanism in human cholangiocyte cell lines. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[56] V. Puri,et al. Sphingolipid Storage Induces Accumulation of Intracellular Cholesterol by Stimulating SREBP-1 Cleavage* , 2003, Journal of Biological Chemistry.
[57] S. Milstien,et al. Molecular Cloning and Functional Characterization of a Novel Mammalian Sphingosine Kinase Type 2 Isoform* , 2000, The Journal of Biological Chemistry.
[58] M. Makishima,et al. Identification of a nuclear receptor for bile acids. , 1999, Science.
[59] J. Lehmann,et al. Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.
[60] Jasmine Chen,et al. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.
[61] S. Glaser,et al. Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes. , 1997, The American journal of physiology.